LB
Leigh Brody
Investment Manager at AlbionVC
London, England
Overview
Leigh Brody is a Biotech Investor at AlbionVC in London, England, with a background in cell biology, molecular biology, and biochemistry. Notable highlights of their career include serving as an Investment Manager at AlbionVC and as an Executive Director of Platform Strategy at Quell Therapeutics, showcasing expertise in biotechnology investments and strategic planning.
Work Experience
Investment Manager, UCL Technology Fund
2021 - Current
The UCL Technology Fund is managed by AlbionVC and is dedicated to investing in the next generation of life-changing innovative technologies, arising from UCL's world-class research base.
Board Director
2022
Member and Angel Investor
2022
Executive Director of Platform Strategy
2019 - 2020
Chief Scientific Officer
2015 - 2019
Founder
2012 - 2014
Founder of a spin-out from my PhD, developing lipid-based nanoparticles (LNPs) for small molecule and mRNA delivery solutions.
Life Science Investor
2013 - 2014
Index Ventures is a venture capital firm that helps the entrepreneurs turn bold ideas into global businesses.
Research Scientist
2005 - 2008
The RNAi Consortium (TRC) - TRC1, 1.5, 2 and Project Achilles.